ebook Munafa Stock Market Course + Intraday & FNO calls  

       

532523 announcements Biocon Ltd. announcements and dividends declared BSE

Biocon Ltd. Complete list of announcements declared & dividend announcements by Biocon Ltd. 532523

Biocon Ltd. 532523 listed on BSE and deals in

Announcements and dividends declared by Biocon Ltd. 532523

Bullish on these 7 sectors; Biocon and Nykaa are two top picks: CA Rudramurthy BV
Expert CA Rudramurthy BV suggests a bullish stance. He recommends buying on dips, especially in pharma stocks like Glenmark, Laurus Labs, and Biocon. Consumer discretionary and FMCG sectors also present opportunities. PSU banks such as SBI and PNB look pro
Announcement as on 11 July 2025

Biocon Biologics gets UK MHRA nod for biosimilars Vevzuo, Evfraxy
Biocon Biologics Ltd has achieved a significant milestone. It has secured marketing authorizations in the UK for Vevzuo and Evfraxy. These are biosimilars of Denosumab. Vevzuo addresses skeletal events in adults with advanced malignancies. Evfraxy treats o
Announcement as on 07 July 2025

Karnataka CM's remarks on covid vaccines 'factually incorrect,' says Biocon chief Kiran Mazumdar-Shaw
Kiran Mazumdar-Shaw refuted Karnataka CM Siddaramaiah's claim. Siddaramaiah linked covid-19 vaccines to heart attack deaths in Hassan. Shaw stated the vaccines followed rigorous safety protocols. She said the vaccines saved lives. The Union Health Ministry
Announcement as on 03 July 2025

Biocon biologics receives European Commission approval for Vevzuo, Evfraxy Denosumab biosimilars for bone diseases
Biocon Ltd's arm, Biocon Biologics Ltd, has received European Commission authorisation for its Vevzuo and Evfraxy biosimilars, used to treat various bone diseases. Vevzuo addresses bone complications in cancer patients and giant cell tumors, while Evfraxy
Announcement as on 03 July 2025

Biocon eyes Canadian bonanza from generics of weight-loss 'super-drugs' Ozempic and Wegovy
Biocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key markets like Canada, where patents expire next year. Managing Director Siddharth Mittal sees Canada as a prime opportunity, aiming for
Announcement as on 02 July 2025

Announcements by Biocon Ltd. first page | Next page | Prev page |

532523 Biocon Ltd. current price & indicator signals

Moving Averages for Biocon Ltd.

  • 5Day Average: 357
  • 12Day Average: 352.79
  • 20Day Average: 356.31
  • 50Day Average: 372.32
  • 100Day Average: 377.69
  • 150Day Average: 375.44
  • 200Day Average: 374.49

532523 Indicators & signals

Indicator MACD (12,26,9)

355.58, 360.72, -6.31
Indicator MACD is in negative zone

Indicator ADX (14)

29.25, 14.65, 26.76
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 38
Indicator RSI is indicating selling pressure and stock might fall.

Recent prices of 532523 Biocon Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
24 Fri Apr 2026 349.65 348.50 to 358.80 -2.28% 0.49 times
23 Thu Apr 2026 357.80 355.80 to 364.70 0.04% 0.44 times
22 Wed Apr 2026 357.65 356.30 to 363.70 -1.04% 0.44 times
21 Tue Apr 2026 361.40 359.00 to 364.60 0.81% 0.37 times
20 Mon Apr 2026 358.50 355.00 to 362.50 0.08% 0.76 times
17 Fri Apr 2026 358.20 349.55 to 358.65 2.18% 0.44 times
16 Thu Apr 2026 350.55 346.95 to 354.90 0.03% 0.62 times
15 Wed Apr 2026 350.45 348.20 to 351.75 1.59% 4.64 times
13 Mon Apr 2026 344.95 338.00 to 346.85 -1.05% 0.91 times
10 Fri Apr 2026 348.60 346.15 to 350.45 0.82% 0.78 times
09 Thu Apr 2026 345.75 344.50 to 351.10 -1.21% 0.62 times
08 Wed Apr 2026 350.00 344.30 to 353.50 2.9% 7.85 times

Videos related to: 532523 announcements Biocon Ltd. announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

532523 announcements Biocon Ltd. announcements and dividends declared BSE

 

Back to top